Metabolic Syndrome

•	Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus Sakurai T, Iimuro S, Araki A, Umegaki H, Ohashi Y, Yokono K, Ito H Gerentology. 2010;56(2):141-149
•	Parental history of type 2 diabetes mellitus, metabolic syndrome, and cardiometabolic risk factors in Asian Indian adolescents Anjana RM, Lakshminarayanan S, Deepa M, Farooq S, Pradeepa R, Mohan V Metabolism. 2009;58(3):344-350
•	Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population Shigetoh Y, Adachi H, Yamagishi S, et al Am J Hypertension.. 2009;22(2):151-155
•	Nateglinide and glibenclamide metabolic effects in naive type 2 diabetic patients treated with metformin Derosa G, D’Angelo A, Fogari E, et al J Clin Pharm Ther. 2009;34(1):13-23
•	The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient Fruchart JC, Sacks FM, Hermans MP, et al, for the Residual Risk Reduction Initiative (R3I) Diab Vasc Dis Res. 2008;5(4):319-35
•	Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline Rosenzweig JL, Ferrannini E, Grundy SM J Clin Endocrinol Metab. 2008;93(10):3671-3689
•	Exercise Training Amount and Intensity Effects on Metabolic Syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Johnson JL, Slentz CA, Houmard JA, Samsa GP, Duscha BD, Aiken LB, McCartney JS, Tanner CJ, Kraus WE. Am J Cardiol.. 100(12):1759-66
•	Comparison of different definitions of the metabolic syndrome Sandhofer A, Iglseder B, Paulweber B, Ebenbichler CF, Patsch JR Eur J Clin Invest. 2007;37:109-116
•	Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women Qiao Q, for The DECODE Study Group Diabetologia. 2006;49:2837-2846
•	Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C Atherosclerosis. 2006;189:369-374
•	Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF 2nd, Kullo IJ Am J Hypertension.. 2007;20:83-89
•	Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome Bakris G, Molitch M, Hewkin A, et al, for the STAR Investigators Diabetes Care. 2006;29:2592-2597
•	Metabolic syndrome is associated with severe coronary artery disease and poor cardiac outcome in end-stage renal disease patients with acute coronary syndrome Chen HH, Wu CJ, Chen YC, Tsai CS, Lin FJ, Yeh HI Coron Artery Dis. 2006;17:593-596
•	Metabolic syndrome and hyperglycemia: congruence and divergence Alexander CM, Landsman PB, Grundy SM Am J Cardiol.. 2006;98:982-985
•	Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome Derosa G, D'Angelo A, Ragonesi PD, et al J Clin Pharm Ther. 2006;31:375-383
•	Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance de Aguiar LG, Bahia LR, Villela N, Laflor C, Sicuro F, Wiernsperger N, Bottino D, Bouskela E Diabetes Care. 2006;29:1083-1089
•	Health promotion in older adults: The role of lifestyle in the metabolic syndrome Firdaus M, Mathew MK, Wright J Geriatrics. 2006;61:18-25
•	Effects of pioglitazone on beta-cell function in metabolic syndrome patients with impaired glucose tolerance Jin J, Yu Y, Yu H, Wang C, Zhang X Diabetes Res Clin Pract. 2006;74:233-241
•	The metabolic syndrome: recognition and management Hall WD, Watkins LO, Wright JT et al Dis Manag. 2006;9:16-33
•	Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men Kurl S, Laukkanen JA, Niskanen L, et al Stroke. 2006
•	Inflammatory markers and the metabolic syndrome insights from therapeutic interventions Koh KK, Han SH, Quon MJ J Am Coll Cardiol. 2005;46:1978-1985
•	The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients Saely CH, Aczel S, Marte T, Langer P, Hoefle G, Drexel H J Clin Endocrinol Metab. 2005;90:5698-5703
•	Association Between Peroxisome Proliferator-Activated Receptor {gamma} Haplotypes and the Metabolic Syndrome in French Men and Women Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J Diabetes. 2005;54:3043-3048
•	Carotid Artery Remodeling in Middle-Aged Women With the Metabolic Syndrome (from the "Progetto ATENA" Study) Iannuzzi A, De Michele M, Bond MG, et al Am J Cardiol.. 2005;96:1162-1165
•	Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents Sookoian S, Garcia SI, Porto PI, Dieuzeide G, Gonzalez CD, Pirola CJ J Mol Endocrinol. 2005;35:373-380
•	What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome? Windler E Atheroscler Suppl. 2005;6:11-14
•	Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study Dekker JM, Girman C, Rhodes T, et al Circulation. 2005;112:666-673
•	Sleep apnea is a manifestation of the metabolic syndrome Vgontzas AN, Bixler EO, Chrousos GP Sleep Med Rev. 2005;9:211-224
•	The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B Stroke. 2005;36:1212-1217
•	Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension Schillaci G, Pirro M, Vaudo G, et al Hypertension. 2005;45:1078-1082
•	The metabolic syndrome: requiescat in pace Reaven GM Clin Chem. 2005;51:931-938
•	Influence of metabolic syndrome on hypertension-related target organ damage Mule G, Nardi E, Cottone S, et al J Intern Med. 2005;257:503-513
•	Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: the Bogalusa Heart Study Li S, Chen W, Srinivasan SR, Berenson GS Atherosclerosis. 2005;180:349-354
•	Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome Onat A, Hergenc G, Keles I, Dogan Y, Turkmen S, Sansoy V Metabolism. 2005;54:800-808
•	Pathophysiology of dyslipidaemia in the metabolic syndrome Kolovou GD, Anagnostopoulou KK, Cokkinos DV Postgrad Med J. 2005;81:358-366
•	Cardiovascular risk: Prevention and treatment of the metabolic syndrome Tuomilehto J Diabetes Res Clin Pract. 2005;68 Suppl 2:S28-S35
•	Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus Schindhelm RK, Diamant M, Bakker SJ, van Dijk RA, Scheffer PG, Teerlink T, Kostense PJ, Heine RJ Eur J Clin Invest. 2005;35:369-374
•	Addressing the Global Cardiovascular Risk of Hypertension Dyslipidemia Diabetes Mellitus and the Metabolic Syndrome... Bestermann W, Houston MC, Basile J, et al Am J Med Sci. 2005;329:292-305
•	The associations between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study Pitsavos C, Panagiotakos DB, Chrysohoou C, Kavouras S, Stefanadis C Eur J Cardiovasc Prev Rehabil. 2005;12:151-158
•	The metabolic syndrome Eckel RH, Grundy SM, Zimmet PZ Lancet. 2005;365:1415-1428
•	The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study Scuteri A, Najjar SS, Morrell CH, Lakatta EG Diabetes Care. 2005;28:882-887
•	The metabolic syndrome and concentrations of C-reactive protein among U.S. youth Ford ES, Ajani UA, Mokdad AH Diabetes Care. 2005;28:878-881
•	The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial Orchard TJ, Temprosa M, Goldberg R, et al. Ann Intern Med. 2005;142:611-619
•	Cardiovascular disease in u.s. Patients with metabolic syndrome, diabetes, and elevated C-reactive protein Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R Diabetes Care. 2005;28:690-693
•	Unexplained Elevations in Alanine Aminotransferase in Individuals with the Metabolic Syndrome: Results from the Third National Health and Nutrition Survey (NHANES III) Liangpunsakul S, Chalasani N Am J Med Sci. 2005;329:111-116
•	Impact of Obesity and the Metabolic Syndrome on Risk Factors in African American Stroke Survivors: A Report From the AAASPS Ruland S, Hung E, Richardson D, Misra S, Gorelick PB Arch Neurol. 2005;62:386-390
•	PPAR Ligands: Potential Therapies for Metabolic Syndrome Akiyama TE, Meinke PT, Berger JP Curr Diab Rep. 2005;5:45-52
•	Role of stress in the pathogenesis of the metabolic syndrome Rosmond R Psychoneuroendocrinology. 2005;30:1-10
•	Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome Salmenniemi U, Ruotsalainen E, Pihlajamaki J, et al Circulation. 2004;110:3842-3848
•	Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001 Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K Diabetes Care. 2004;27:2707-2715
•	Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM J Pediatr. 2004;145:445-451
•	Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N Circulation. 2004;110:2494-2497
•	Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome Christ M, Iannello C, Iannello PG, Grimm W Int J Cardiol.. 2004;97:115-122
•	Increasing prevalence of the metabolic syndrome among U.S. Adults Ford ES, Giles WH, Mokdad AH Diabetes Care. 2004;27:2444-2449
•	Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial Esposito K, Marfella R, Ciotola M, et al JAMA. 2004;292:1440-1446
•	Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000 Duncan GE, Li SM, Zhou XH Diabetes Care. 2004;27:2438-2443
•	Associations between the Metabolic Syndrome and Retinal Microvascular Signs: The Atherosclerosis Risk in Communities Study Wong TY, Duncan BB, Golden SH, et al Invest Ophthalmol Vis Sci. 2004:45:2949-2954
•	Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults Malik S, Wong ND, Franklin SS Circulation. 2004;110:1239-1244
•	Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse Ueki K, Kondo T, Tseng YH, Kahn CR Proc Natl Acad Sci USA. 2004;101:10422-10427
•	Cardiovascular Risk Factors in Childhood and Carotid Artery Intima-Media Thickness in Adulthood Raitakari OT, Juonala M, Kähönen M, et al JAMA. 2003;290:2277-2283
•	Identification of Subjects with Insulin Resistance and ß-Cell Dysfunction Using Alternative Definitions of the Metabolic Syndrome Hanley AJG, Wagenknecht LE, D’Agostino, Jr. RB, Zinman B, Haffner SM Diabetes. 2003;52:2740-2747
•	Diabetes, Insulin Resistance, and the Metabolic Syndrome in Patients With Acute Myocardial Infarction Without Previously Known Diabetes Tenerz Å, Norhammar A, Silveira A, et al Diabetes Care. 2003;26:2770-2776
•	Low Insulin Sensitivity (Si = 0) in Diabetic and Nondiabetic Subjects in the Insulin Resistance Atherosclerosis Study. Is it associated with components of the metabolic syndrome and nontraditional risk factors? Haffner SM, D’Agostino R Jr., Festa A, et al Diabetes Care. 2003;26:2796-2803
•	Early Postpartum Metabolic Assessment in Women With Prior Gestational Diabetes

Clinical Bridges, Secaucus, NJ
Clinical Bridges is a division of KnowledgePoint360 Group, LLC.
Copyright © 2009 Clinical Bridges. All rights reserved.
National Diabetes Education Initiative, Clinical Bridges, and
KnowledgePoint360 are trademarks of KnowledgePoint360 Group, LLC.

Disclaimer Statement - Privacy Statement